[144] StoneCo Ltd. SEC Filing
StoneCo Ltd. (STNE) filed a Form 144 notifying the proposed sale of 100,000 common shares with an aggregate market value of $1,539,000.00. The sale is scheduled for 08/14/2025 on NASDAQ through Morgan Stanley Smith Barney LLC. The filing shows these shares were acquired as restricted stock vesting under a registered plan and issued as compensation in three tranches: 85,545 shares on 12/19/2023, 6,476 shares on 05/22/2024, and 7,979 shares on 09/04/2024, which together equal the 100,000 shares to be sold. No sales by the reporting person are reported in the prior three months, and the filer attests they have no undisclosed material adverse information about the issuer.
- Compliance: Form 144 filed and sale routed through a registered broker (Morgan Stanley Smith Barney LLC), indicating procedural compliance with Rule 144.
- Clarity of acquisition: All shares to be sold were disclosed as restricted stock vesting and issued as compensation with specific acquisition dates and quantities that sum to the total 100,000 shares.
- Limited market impact: 100,000 shares represent a very small fraction (~0.037%) of the reported 269,087,488 shares outstanding.
- None.
Insights
TL;DR: Insignificant volume relative to total shares outstanding; confirms routine post-vesting disposition under Rule 144.
The proposed sale of 100,000 shares represents roughly 0.037% of the issuer's reported 269,087,488 shares outstanding, indicating limited dilution or market impact. The acquisition entries show the shares were received as compensation via restricted stock vesting across three dates in 2023-2024, and the planned use of a broker (Morgan Stanley Smith Barney LLC) and a Form 144 filing are consistent with compliance steps under Rule 144. No prior sales in the past three months are reported, which may reflect a single-event disposition following vesting rather than an ongoing selling pattern.
TL;DR: Filing documents a compliant, routine insider sale post-vesting with standard representations about material information.
The statement that the securities were acquired through restricted stock vesting under a registered plan and paid as compensation is standard for executive equity awards. The signer’s attestation that they are unaware of undisclosed material adverse information is the required certification on Form 144. No indications of unusual trading plans, aggregated sales, or recent related-party transactions are shown in the filing text provided.